Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D Rhoads

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2021
Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: An Infectious Diseases Society of America/American Society for Microbiology Consensus Review DocumentAlexander L Greninger, Jennifer Dien Bard, Robert C Colgrove, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2025
Navigating Nomenclature in Patient Care: Taxonomy Considerations From the College of American Pathologists' Microbiology CommitteeJennifer Dien Bard, Kaede V Sullivan, Sean X Zhang, et al.
Journal of Clinical Microbiology|November 3, 2021
Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: an Infectious Diseases Society of America/American Society for Microbiology Consensus Review DocumentAlexander L Greninger, Jennifer Dien Bard, Robert C Colgrove, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2018
ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and <i>Enterobacteriaceae</i> with Defined Extended-Spectrum β-Lactamases and CarbapenemasesMichael R Jacobs, Ayman M Abdelhamed, Caryn E Good, et al.
Journal of Clinical Microbiology|February 9, 2022
Multicenter Evaluation of the Acuitas AMR Gene Panel for Detection of an Extended Panel of Antimicrobial Resistance Genes among Bacterial IsolatesPatricia J Simner, Kimberlee A Musser, Kara Mitchell, et al.
Journal of Clinical Microbiology|May 25, 2023
Multicenter Evaluation of the BIOFIRE Blood Culture Identification 2 Panel for Detection of Bacteria, Yeasts, and Antimicrobial Resistance Genes in Positive Blood Culture SamplesDaniel D Rhoads, Spyros Pournaras, Amy Leber, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2024
ARGONAUT-IV: susceptibility of carbapenemase-producing <i>Klebsiella pneumoniae</i> to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibutenMichael R Jacobs, Caryn E Good, Ayman M Abdelhamed, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2024
ARGONAUT-III and -V: susceptibility of carbapenem-resistant <i>Klebsiella pneumoniae</i> and multidrug-resistant <i>Pseudomonas aeruginosa</i> to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepimeMichael R Jacobs, Ayman M Abdelhamed, Caryn E Good, et al.
Journal of Clinical Microbiology|July 11, 2025
Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritisWendy A Szymczak, Anne Line Engsbro, Jan Gorm Lisby, et al.
Plos One|March 31, 2022
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testingLaura J Rojas, Mohamad Yasmin, Jacquelynn Benjamino, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2021
Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: An Infectious Diseases Society of America/American Society for Microbiology Consensus Review DocumentAlexander L Greninger, Jennifer Dien Bard, Robert C Colgrove, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2025
Navigating Nomenclature in Patient Care: Taxonomy Considerations From the College of American Pathologists' Microbiology CommitteeJennifer Dien Bard, Kaede V Sullivan, Sean X Zhang, et al.
Journal of Clinical Microbiology|November 3, 2021
Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: an Infectious Diseases Society of America/American Society for Microbiology Consensus Review DocumentAlexander L Greninger, Jennifer Dien Bard, Robert C Colgrove, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2018
ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and <i>Enterobacteriaceae</i> with Defined Extended-Spectrum β-Lactamases and CarbapenemasesMichael R Jacobs, Ayman M Abdelhamed, Caryn E Good, et al.
Journal of Clinical Microbiology|February 9, 2022
Multicenter Evaluation of the Acuitas AMR Gene Panel for Detection of an Extended Panel of Antimicrobial Resistance Genes among Bacterial IsolatesPatricia J Simner, Kimberlee A Musser, Kara Mitchell, et al.
Journal of Clinical Microbiology|May 25, 2023
Multicenter Evaluation of the BIOFIRE Blood Culture Identification 2 Panel for Detection of Bacteria, Yeasts, and Antimicrobial Resistance Genes in Positive Blood Culture SamplesDaniel D Rhoads, Spyros Pournaras, Amy Leber, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2024
ARGONAUT-IV: susceptibility of carbapenemase-producing <i>Klebsiella pneumoniae</i> to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibutenMichael R Jacobs, Caryn E Good, Ayman M Abdelhamed, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2024
ARGONAUT-III and -V: susceptibility of carbapenem-resistant <i>Klebsiella pneumoniae</i> and multidrug-resistant <i>Pseudomonas aeruginosa</i> to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepimeMichael R Jacobs, Ayman M Abdelhamed, Caryn E Good, et al.
Journal of Clinical Microbiology|July 11, 2025
Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritisWendy A Szymczak, Anne Line Engsbro, Jan Gorm Lisby, et al.
Plos One|March 31, 2022
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testingLaura J Rojas, Mohamad Yasmin, Jacquelynn Benjamino, et al.
Pageof 9